Active Filter(s):
Details:
The partnership aims to launch SunWay's inaugural product, MenaQ7® Metabolic, featuring two key active ingredients, MenaQ7® Vitamin K2 as MK-7 and ANKASCIN® 568-R.
Lead Product(s): Menaquinone-7,Ankascin 568-R
Therapeutic Area: Cardiology/Vascular Diseases Product Name: MenaQ7
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: Gnosis by Lesaffre
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership March 14, 2024